These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36638349)
1. Zhang R; Wang H; Xiao J; Lu J; Li M; Zhou Y; Sun H; Liu L; Huang T; Zhao Q DNA Cell Biol; 2023 Jan; 42(1):27-42. PubMed ID: 36638349 [TBL] [Abstract][Full Text] [Related]
2. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer. Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S Front Immunol; 2024; 15():1295011. PubMed ID: 38562942 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer. Chen Y; Huang X; Chen L; Weng G; Huang Z; Zhang Y; Xiao T; Chen J; Zhu K; Xu Y Mol Biotechnol; 2023 Mar; 65(3):361-383. PubMed ID: 35780460 [TBL] [Abstract][Full Text] [Related]
4. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Hu J; Yu A; Othmane B; Qiu D; Li H; Li C; Liu P; Ren W; Chen M; Gong G; Guo X; Zhang H; Chen J; Zu X Theranostics; 2021; 11(7):3089-3108. PubMed ID: 33537076 [No Abstract] [Full Text] [Related]
5. Identification of enhancer RNA Jia L; Chen J; Zhao J; Yang J Transl Cancer Res; 2023 Dec; 12(12):3266-3283. PubMed ID: 38192978 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients. Yuan W; Yan J; Liu H; Li L; Wu B; Guo C; Zhang M Pathol Oncol Res; 2021; 27():589662. PubMed ID: 34257539 [No Abstract] [Full Text] [Related]
8. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures. Zhang Y; Zhu M; Mo J; Xian L Aging (Albany NY); 2021 Dec; 13(24):26118-26136. PubMed ID: 34954689 [TBL] [Abstract][Full Text] [Related]
10. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies. Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930 [TBL] [Abstract][Full Text] [Related]
11. Dissecting the molecular profiling and tumor immune microenvironment of three subtypes of esophageal cancer. Yu C; Xi Y; Zhang P; He N; Shen W J Gene Med; 2023 May; 25(5):e3482. PubMed ID: 36786041 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study. Vered M; Lehtonen M; Hotakainen L; Pirilä E; Teppo S; Nyberg P; Sormunen R; Zlotogorski-Hurvitz A; Salo T; Dayan D BMC Cancer; 2015 Jan; 15():25. PubMed ID: 25633184 [TBL] [Abstract][Full Text] [Related]
13. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment. Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z Front Immunol; 2021; 12():691811. PubMed ID: 34489938 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer. Mei PY; Xiao H; Guo Q; Meng WY; Wang ML; Huang QF; Liao YD Oncol Lett; 2023 Feb; 25(2):68. PubMed ID: 36644145 [TBL] [Abstract][Full Text] [Related]
15. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis. Ye Y; Jiang H; Wu Y; Wang G; Huang Y; Sun W; Zhang M Front Mol Biosci; 2022; 9():1001225. PubMed ID: 36213111 [No Abstract] [Full Text] [Related]
16. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer. Du H; Pang S; Li Y; Zhu L; Hang J; Chen L J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327 [TBL] [Abstract][Full Text] [Related]
17. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer. Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X Front Immunol; 2021; 12():725223. PubMed ID: 34484235 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia inhibits the iMo/cDC2/CD8+ TRMs immune axis in the tumor microenvironment of human esophageal cancer. Wu C; Yu H; Liang F; Huang X; Jiang B; Lou Z; Liu Y; Wu Z; Wang Q; Shen H; Chen M; Wu P; Wu M J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 38964786 [TBL] [Abstract][Full Text] [Related]
19. eIF6 is potential diagnostic and prognostic biomarker that associated with Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622 [TBL] [Abstract][Full Text] [Related]
20. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment. Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]